English
Senores Pharmaceuticals Q3 Results
- BSE: 544319
- NSE: SENORES
- ISIN: INE0RB801010
- Sector: Biotechnology & Drugs
BSE
777.40
-6.85 (-0.87%)
-6.85 (-0.87%)Volume8.68 K
Updated: Fri 5 Dec, 2025 | 15:53:19
NSE
776.75-9.75 (-1.24%)
-9.75 (-1.24%)Volume2.22 L
Updated: Fri 5 Dec, 2025 | 15:55:32
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Senores Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 81.54 | 81.27 | 0.33% |
| Depreciation/ Amortization | 4.20 | 3.89 | 7.97% |
| Operating Income | 21.48 | 19.36 | 10.95% |
| Net Income | 17.17 | 12.84 | 33.72% |
| Other Operating Expenses Total | 17.63 | 14.76 | 19.44% |
| Net Income Before Taxes | 20.48 | 15.95 | 28.40% |
| Total Revenue | 103.02 | 100.63 | 2.38% |
| Selling/ General/ Admin Expenses Total | 19.01 | 14.70 | 29.32% |
| Diluted Normalized EPS | 5.04 | 3.92 | 28.57% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.